SCHEMBL19567992

SCHEMBL19567992

CCc1cccc(NS(C)(=O)=O)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.49
KEAP1 Q14145 2/20 0.49
NFE2L2 Q16236 1/20 0.49
NR3C1 P04150 6/20 0.44
PSIP1 O75475 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GLO1 Q04760 2/20 0.42
PGR P06401 2/20 0.42
NR3C2 P08235 2/20 0.42
AR P10275 2/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
PLA2G7 Q13093 1/20 0.41
ALDH1A1 P00352 2/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
KDM4E B2RXH2 1/20 0.40
RCE1 Q9Y256 1/20 0.40
KAT6A Q92794 1/20 0.40
BRAF P15056 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19567993 0.90 KEAP1 (0.46) PTGS1KEAP1NFE2L2NR3C1PSIP1
SCHEMBL20782061 0.83 KEAP1 (0.44) PTGS1KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL5186762 0.81 PTGS1 (0.62) PTGS1KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL13869170 0.80 KEAP1 (0.65) PTGS1KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL26386536 0.80 KEAP1 (0.50) KEAP1NFE2L2NR3C1L3MBTL1GLO1
SCHEMBL2642570 0.79 KEAP1 (0.53) KEAP1NFE2L2NR3C1PSIP1L3MBTL1
SCHEMBL8607408 0.79 GABRA1 (0.55) PTGS1KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL27275056 0.78 KEAP1 (0.52) PTGS1KEAP1NFE2L2NR3C1L3MBTL1
SCHEMBL19541406 0.77 GABRA1 (0.41) PSIP1L3MBTL1ARHTTALDH1A1
SCHEMBL21870755 0.76 KEAP1 (0.50) KEAP1NFE2L2NR3C1L3MBTL1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 EP disclosed
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 WO disclosed